Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Broncus HoldingHKSE:02216 +1.55%43 Days Inventory is 626.86 as of Jun. 2026, which is 15% below its 10-year median of 739.15. GuruFocus rates HKSE:02216 with a GF Score™ of 43/100 and a GF Value™ of HK$0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Broncus Holding ranks worse than 95.05% on this metric.
The historical rank and industry rank for Broncus Holding's Days Inventory or its related term are showing as below:
HKSE:02216'
s Days Inventory Range Over the Past 10 Years
Min: 318.64 Med: 739.15 Max: 1247.96
Current: 765.28
During the past 7 years, Broncus Holding's highest Days Inventory was 1247.96. The lowest was 318.64. And the median was 739.15.
HKSE:02216's Days Inventory is ranked worse than 95.05% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 177.785
vs HKSE:02216: 765.28
Broncus Holding's Days Inventory
declined
from Jun. 2025 (1,463.29) to Jun. 2026 (626.86).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Broncus Holding's Inventory Turnover for the
six
months ended in Jun. 2026 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Broncus Holding's Inventory-to-Revenue for the
six
months ended in Jun. 2026 was 1.10.
Broncus Holding (HKSE:02216) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Broncus Holding's Inventory Turnover for the
six
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Broncus Holding's Inventory to Revenue for the
six
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Broncus Holding Days Inventory Related Terms
Broncus Holding Days Inventory Historical Data
* Premium members only.
The historical data trend for Broncus Holding's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02216 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Broncus Holding's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Days Inventory distribution charts can be found below:
* The bar in red indicates where Broncus Holding's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (HKSE:02216) has a Days Inventory of 626.86 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Broncus Holding and its competitors. This is 15% below median its historical median of 739.15. Over the past decade, Broncus Holding's Days Inventory has ranged from 318.64 to 1,247.96. According to the industry distribution chart, Broncus Holding ranks #749 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 95.1%.
Is Broncus Holding's Days Inventory too high?
Broncus Holding's current Days Inventory of 626.86 is 15% below median its 10-year median of 739.15. Over the past 10 years, this metric has ranged from a low of 318.64 to a high of 1,247.96. The Medical Devices & Instruments industry median Days Inventory is 177.79. Broncus Holding's value of 626.86 is 252.6% above this industry median. Based on the distribution chart, Broncus Holding ranks #749 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Broncus Holding has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #749 out of 788 companies for Days Inventory. This places Broncus Holding in the lower half of its industry. The industry median Days Inventory is 177.79. Broncus Holding's value of 626.86 is 252.6% above this benchmark. Historically, Broncus Holding's own Days Inventory has ranged from 318.64 to 1,247.96 over the past decade. While the company's 10-year median is 739.15 vs. the industry median of 177.79, Broncus Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 177.79, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Broncus Holding's current Days Inventory of 626.86 is 252.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Broncus Holding and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 177.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current Days Inventory is 626.86, which is 15% below median its own 10-year median of 739.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Based on GuruFocus' analysis, Broncus Holding (HKSE:02216) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.66 — trading 336.7% above its estimated fair value. The current Days Inventory is 626.86, which is 15% below median its 10-year median of 739.15 and 252.6% above the Medical Devices & Instruments industry median of 177.79. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Broncus Holding (HKSE:02216), the current Days Inventory is 626.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Broncus Holding (HKSE:02216) Overvalued in 2026?
Based on GuruFocus' analysis, Broncus Holding stock appears to be overvalued.
The current stock price of HK$0.66 is trading 336.7% above its estimated GF Value™ of HK$0.15.
GuruFocus considers Broncus Holding to be Significantly Overvalued.
Key valuation signals for HKSE:02216:
Days Inventory: 626.86 (15% below median its 10-year median of 739.15)
GF Value™: HK$0.15 vs. price of HK$0.66 (336.7% above fair value)
Industry Position: 252.6% above the Medical Devices & Instruments median (#749 of 788)
No single metric tells the full story. See the HKSE:02216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for HKSE:02216
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02216 has been successfully added to your 
